Annual ROE
-61.91%
-19.72%-46.74%
31 December 2022
Summary:
Mirati Therapeutics annual return on equity is currently -61.91%, with the most recent change of -19.72% (-46.74%) on 31 December 2022. During the last 3 years, it has fallen by -19.72% (-46.74%).MRTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-77.82%
-1.46%-1.91%
30 September 2023
Summary:
Mirati Therapeutics quarterly return on equity is currently -77.82%, with the most recent change of -1.46% (-1.91%) on 30 September 2023.MRTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -46.7% | -66.7% |
| 5 y5 years | +15.1% | -29.7% |
MRTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | +260.8% | +1002.3% |
Mirati Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -77.82%(+1.9%) |
| June 2023 | - | -76.36%(+10.8%) |
| Mar 2023 | - | -68.89%(+9.4%) |
| Dec 2022 | -61.91%(+46.7%) | -62.96%(+1.9%) |
| Sept 2022 | - | -61.80%(+14.5%) |
| June 2022 | - | -53.97%(+4.1%) |
| Mar 2022 | - | -51.84%(+11.1%) |
| Dec 2021 | -42.19%(+2.7%) | -46.68%(+3.9%) |
| Sept 2021 | - | -44.92%(-10.4%) |
| June 2021 | - | -50.13%(+9.2%) |
| Mar 2021 | - | -45.89%(-8.8%) |
| Dec 2020 | -41.07%(-43.7%) | -50.31%(-19.5%) |
| Sept 2020 | - | -62.47%(+8.2%) |
| June 2020 | - | -57.73%(-0.5%) |
| Mar 2020 | - | -58.04%(-3.2%) |
| Dec 2019 | -72.91%(+27.7%) | -59.98%(+15.0%) |
| Sept 2019 | - | -52.16%(+5.0%) |
| June 2019 | - | -49.69%(-12.4%) |
| Mar 2019 | - | -56.73%(+10.0%) |
| Dec 2018 | -57.08%(-22.4%) | -51.57%(-3.9%) |
| Sept 2018 | - | -53.69%(-5.4%) |
| June 2018 | - | -56.74%(-11.0%) |
| Mar 2018 | - | -63.74%(-20.1%) |
| Dec 2017 | -73.58%(-26.3%) | -79.80%(-19.7%) |
| Sept 2017 | - | -99.36%(-0.4%) |
| June 2017 | - | -99.78%(+0.2%) |
| Mar 2017 | - | -99.60%(-0.4%) |
| Dec 2016 | -99.88%(+13.2%) | -99.98%(+22.6%) |
| Sept 2016 | - | -81.53%(-1.3%) |
| June 2016 | - | -82.59%(+5.5%) |
| Mar 2016 | - | -78.30%(-2.4%) |
| Dec 2015 | -88.22%(-45.5%) | -80.26%(-9.3%) |
| Sept 2015 | - | -88.47%(-27.4%) |
| June 2015 | - | -121.89%(-13.3%) |
| Mar 2015 | - | -140.60%(-30.4%) |
| Dec 2014 | -161.95% | -202.05%(-48.8%) |
| Sept 2014 | - | -394.25%(-67.4%) |
| June 2014 | - | -1210.27%(+88.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -643.03%(+68.5%) |
| Dec 2013 | -175.36%(+166.3%) | -381.66%(-6.4%) |
| Sept 2013 | - | -407.77%(+240.9%) |
| June 2013 | - | -119.63%(+36.8%) |
| Mar 2013 | - | -87.43%(+5.0%) |
| Dec 2012 | -65.85%(+8.0%) | -83.24%(+11.0%) |
| Sept 2012 | - | -74.97%(+40.1%) |
| June 2012 | - | -53.50%(+11.3%) |
| Mar 2012 | - | -48.08%(-2.7%) |
| Dec 2011 | -60.96%(-66.7%) | -49.40%(-9.7%) |
| Sept 2011 | - | -54.70%(-37.9%) |
| June 2011 | - | -88.08%(-54.1%) |
| Mar 2011 | - | -191.94%(+5.2%) |
| Dec 2010 | -183.17%(+65.9%) | -182.44%(+6.9%) |
| Sept 2010 | - | -170.70%(+22.6%) |
| June 2010 | - | -139.23%(+3.3%) |
| Mar 2010 | - | -134.72%(+25.0%) |
| Dec 2009 | -110.40%(+461.5%) | -107.78%(+202.8%) |
| Sept 2009 | - | -35.59%(+50.4%) |
| June 2009 | - | -23.67%(-4.3%) |
| Mar 2009 | - | -24.74%(+11.4%) |
| Dec 2008 | -19.66%(-61.6%) | -22.20%(-61.2%) |
| Sept 2008 | - | -57.23%(+2.0%) |
| June 2008 | - | -56.13%(+16.6%) |
| Mar 2008 | - | -48.12%(+11.5%) |
| Dec 2007 | -51.18%(+159.5%) | -43.17%(+32.5%) |
| Sept 2007 | - | -32.57%(+99.1%) |
| June 2007 | - | -16.36%(+23.3%) |
| Mar 2007 | - | -13.27%(-25.3%) |
| Dec 2006 | -19.72%(-55.4%) | -17.77%(-32.9%) |
| Sept 2006 | - | -26.49%(-46.5%) |
| June 2006 | - | -49.53%(-2.3%) |
| Mar 2006 | - | -50.71%(+13.2%) |
| Dec 2005 | -44.24%(+45.0%) | -44.81%(+56.6%) |
| Sept 2005 | - | -28.61%(+68.6%) |
| June 2005 | - | -16.97%(+140.4%) |
| Mar 2005 | - | -7.06% |
| Dec 2004 | -30.51%(+77.8%) | - |
| Dec 2003 | -17.16% | - |
FAQ
- What is Mirati Therapeutics annual return on equity?
- What is the all time high annual ROE for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Mirati Therapeutics?
What is Mirati Therapeutics annual return on equity?
The current annual ROE of MRTX is -61.91%
What is the all time high annual ROE for Mirati Therapeutics?
Mirati Therapeutics all-time high annual return on equity is -17.16%
What is Mirati Therapeutics quarterly return on equity?
The current quarterly ROE of MRTX is -77.82%
What is the all time high quarterly ROE for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly return on equity is -7.06%